146 related articles for article (PubMed ID: 34112264)
1. Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.
Huang X; Chen C; Zhong M; Geng S; Zhao Y; Li M; Deng C; Zeng L; Wu P; Lu Z; Weng J; Du X; Li Y
Biomark Res; 2021 Jun; 9(1):46. PubMed ID: 34112264
[TBL] [Abstract][Full Text] [Related]
2. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
3. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
4. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
[TBL] [Abstract][Full Text] [Related]
5. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia.
Li K; Chen C; Gao R; Yu X; Huang Y; Chen Z; Liu Z; Chen S; Luo G; Huang X; Przybylski GK; Li Y; Zeng C
Biomark Res; 2021 Mar; 9(1):17. PubMed ID: 33663588
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML.
Bauer M; Jäkel N; Wilfer A; Haak A; Eszlinger M; Kelemen K; Haemmerle M; Al-Ali HK; Seliger B; Wickenhauser C
Oncoimmunology; 2024; 13(1):2323212. PubMed ID: 38481730
[TBL] [Abstract][Full Text] [Related]
9. High Co-Expression of
Zhong M; Chen C; Zhao W; Tan J; Chen J; Huang X; Li Y; Dai M
J Oncol; 2023; 2023():1972127. PubMed ID: 36816361
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome.
Yang WC; Lin SF; Wang SC; Tsai WC; Wu CC; Wu SC
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344823
[TBL] [Abstract][Full Text] [Related]
11. Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34
Bauer M; Vaxevanis C; Al-Ali HK; Jaekel N; Naumann CLH; Schaffrath J; Rau A; Seliger B; Wickenhauser C
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430322
[No Abstract] [Full Text] [Related]
12. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
[TBL] [Abstract][Full Text] [Related]
13. High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma.
Chen C; Chen S; Luo G; Wang L; Zeng C; Przybylski GK; Li Y
Biomark Res; 2022 Jul; 10(1):46. PubMed ID: 35831833
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative Analysis on Immunophenotype of CD34
Chen X; Ren FG; Zhang YF; Xu J; Xia T; Chang JM; Chen XH; Tan YH; Wang HW; Xu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):832-839. PubMed ID: 34105480
[TBL] [Abstract][Full Text] [Related]
15. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
[TBL] [Abstract][Full Text] [Related]
16. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
Dan C; Chi J; Wang L
Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes.
Picou F; Vignon C; Debeissat C; Lachot S; Kosmider O; Gallay N; Foucault A; Estienne MH; Ravalet N; Bene MC; Domenech J; Gyan E; Fontenay M; Herault O
Blood Adv; 2019 Dec; 3(24):4271-4279. PubMed ID: 31869414
[TBL] [Abstract][Full Text] [Related]
19. The role of BCL11B in regulating the proliferation of human naive T cells.
Chen S; Huang X; Chen S; Yang L; Shen Q; Zheng H; Li B; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hum Immunol; 2012 May; 73(5):456-64. PubMed ID: 22426257
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]